Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series Consistent COVID-19 hospitalization rates in this age group coupled with an overall surge in respiratory illnesses
The great mRNA pioneers are in legal battles over patents. With a counterclaim, Biontech and its US partner are defending themselves against allegations that could become expensive.
BioNTech’s Omicron-specific vaccine is now available to uninfected adults as a fourth dose or for recovered patients with two jabs as a third dose.
Pfizer and BioNTech said Friday their latest Omicron BA.4/BA.5-adapted bivalent COVID-19 booster vaccine also shows effectiveness against new subvariants of the virus. The companies said in a... | November 18, 2022
Also an mRNA manufacturing facility, it will see new roles across functions such as HR, operations, engineering, quality, finance, and supply chain management, with recruiting starting immediately for first positions.